{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:12Z","timestamp":1790716572168,"version":"4.1.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Cardiovascular diseases have multifactorial causes. Classical cardiovascular risk factors, such as arterial hypertension, smoking, hyperlipidemia, and diabetes associate with the development of vascular stenoses and coronary heart disease. Further comorbidities and its impact on cardiovascular metabolism have gotten more attention recently. Thus, also cancer biology may affect the heart, apart from cardiotoxic side effects of chemotherapies. Cancer is a systemic disease which primarily leads to metabolic alterations within the tumor. An emerging number of preclinical and clinical studies focuses on the interaction between cancer and a maladaptive crosstalk to the heart. Cachexia and sarcopenia can have dramatic consequences for many organ functions, including cardiac wasting and heart failure. These complications significantly increase mortality and morbidity of heart failure and cancer patients. There are concurrent metabolic changes in fatty acid oxidation (FAO) and glucose utilization in heart failure as well as in cancer, involving central molecular regulators, such as PGC-1\u03b1. Further, specific inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1, INF-\u03b2), non-inflammatory cytokines (myostatin, SerpinA3, Ataxin-10) and circulating metabolites (D2-HG) may mediate a direct and maladaptive crosstalk of both diseases. Additionally, cancer therapies, such as anthracyclines and angiogenesis inhibitors target common metabolic mechanisms in cardiomyocytes and malignant cells. This review focuses on cardiovascular, cancerous, and cancer therapy-associated alterations on the systemic and cardiac metabolic state.<\/jats:p>","DOI":"10.3389\/fphys.2021.729713","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:40:39Z","timestamp":1638326439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Cancer\u2014A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism"],"prefix":"10.3389","volume":"12","author":[{"given":"Daniel","family":"Finke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus B.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz H.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/s0002-9149(97)00159-8","article-title":"Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.","volume":"79","author":"Anker","year":"","journal-title":"Am. J. Cardiol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure.","volume":"349","author":"Anker","year":"","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: an overview.","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment.","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha.","volume":"103","author":"Arany","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis.","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ejhf.399","article-title":"Intercellular communication lessons in heart failure.","volume":"17","author":"Bang","year":"2015","journal-title":"Eur. J. Heart Fail"},{"key":"B8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ehf2.12184","article-title":"Cardiac muscle wasting in individuals with cancer cachexia.","volume":"4","author":"Barkhudaryan","year":"2017","journal-title":"ESC Heart Fail."},{"key":"B9","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.274.29.20281","article-title":"Regulation of GLUT1 gene transcription by the serine\/threonine kinase Akt1.","volume":"274","author":"Barthel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1078-0432.CCR-07-1033","article-title":"Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.","volume":"14","author":"Bird","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B12","first-page":"198","article-title":"The metabolic modulator PGC-1alpha in cancer.","volume":"9","author":"Bost","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"B13","first-page":"5488","article-title":"Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.","volume":"60","author":"Cahlin","year":"2000","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/onc.2010.41","article-title":"Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.","volume":"29","author":"Caldwell","year":"2010","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/jci36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B16","first-page":"887","article-title":"[A new frontier: cardio-oncology].","volume":"41","author":"Cardinale","year":"1996","journal-title":"Cardiologia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/circulationaha.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2562","DOI":"10.1038\/cddis.2016.492","article-title":"Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress.","volume":"8","author":"Chan","year":"2017","journal-title":"Cell Death Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.96.6.3047","article-title":"An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect.","volume":"96","author":"Chesney","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine Metabolism in Cancer: understanding the Heterogeneity.","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1042\/bj0221289","article-title":"The carbohydrate metabolism of certain pathological overgrowths.","volume":"22","author":"Crabtree","year":"1928","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","article-title":"Circulating microRNAs are new and sensitive biomarkers of myocardial infarction.","volume":"31","author":"D\u2019Alessandra","year":"2010","journal-title":"Eur. Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.clnu.2020.10.050","article-title":"Myokines in treatment-naive patients with cancer-associated cachexia.","volume":"40","author":"de Castro","year":"2021","journal-title":"Clin. Nutr."},{"key":"B24","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.111.037572","article-title":"Transcoronary concentration gradients of circulating microRNAs.","volume":"124","author":"De Rosa","year":"2011","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis.","volume":"109","author":"Demers","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy.","volume":"6","author":"Duan","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/1099800414558087","article-title":"Induction of IL-6 by Cytotoxic Chemotherapy Is Associated With Loss of Lean Body and Fat Mass in Tumor-free Female Mice.","volume":"17","author":"Elsea","year":"2015","journal-title":"Biol. Res. Nurs."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.molcel.2014.04.026","article-title":"O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.","volume":"54","author":"Ferrer","year":"2014","journal-title":"Mol. Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1016\/j.jmb.2016.05.028","article-title":"O-GlcNAcylation in Cancer Biology: linking metabolism and signaling.","volume":"428","author":"Ferrer","year":"2016","journal-title":"J. Mol. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1161\/atvbaha.111.226696","article-title":"Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?","volume":"31","author":"Fichtlscherer","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1002\/ehf2.13515","article-title":"High-sensitivity cardiac troponin T determines all-cause mortality in cancer patients: a single-centre cohort study.","volume":"8","author":"Finke","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/cvr\/cvu025","article-title":"Cardiac macrophages and their role in ischaemic heart disease.","volume":"102","author":"Frantz","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"B34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women.","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","article-title":"The risk of cardiovascular disease following breast cancer by Framingham risk score.","volume":"170","author":"Gernaat","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.091415198","article-title":"A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.","volume":"98","author":"Giordano","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy.","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol. (1985)"},{"key":"B38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ehf2.12475","article-title":"Evidence for a cardiac metabolic switch in patients with Hodgkin\u2019s lymphoma.","volume":"6","author":"Heckmann","year":"2019","journal-title":"ESC Heart Fail."},{"key":"B39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","article-title":"Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.","volume":"121","author":"Heineke","year":"2010","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","article-title":"Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020).","volume":"13","author":"Huang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.117.029733","article-title":"Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart.","volume":"137","author":"Jabs","year":"2018","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","article-title":"Genetics of inherited cardiomyopathy.","volume":"33","author":"Jacoby","year":"2012","journal-title":"Eur. Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/01.RES.0000083489.83704.76","article-title":"Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.","volume":"93","author":"Jain","year":"2003","journal-title":"Circ. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.1073\/pnas.241380298","article-title":"Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection.","volume":"98","author":"Kanai","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fcvm.2018.00071","article-title":"Actionable metabolic pathways in heart failure and cancer-lessons from cancer cell metabolism.","volume":"5","author":"Karlstaedt","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"10436","DOI":"10.1073\/pnas.1601650113","article-title":"Oncometabolite d-2-hydroxyglutarate impairs alpha-ketoglutarate dehydrogenase and contractile function in rodent heart.","volume":"113","author":"Karlstaedt","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41375-020-01043-x","article-title":"IDH1\/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.","volume":"35","author":"Kattih","year":"2021","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ageing\/25.2.144","article-title":"Fat malabsorption in elderly patients with cardiac cachexia.","volume":"25","author":"King","year":"1996","journal-title":"Age Ageing"},{"key":"B49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/emmm.201303147","article-title":"VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.","volume":"6","author":"Kivela","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming.","volume":"26","author":"Koelwyn","year":"2020","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/circulationaha.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer.","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/0008-5472.177.65.1","article-title":"Glycolytic enzymes can modulate cellular life span.","volume":"65","author":"Kondoh","year":"2005","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.117.031942","article-title":"O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure.","volume":"140","author":"Kronlage","year":"2019","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10753-021-01429-8","article-title":"The Emerging Role of Interleukin 1beta (IL-1beta) in Cancer Cachexia. Inflammation.","volume":"44","author":"Laird","year":"2021","journal-title":"Inflammation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e002183","DOI":"10.1161\/JAHA.115.002183","article-title":"Intracellular Na+ Concentration ([Na+]i) is elevated in diabetic hearts due to enhanced Na+-glucose cotransport.","volume":"4","author":"Lambert","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","article-title":"Cardiovascular Risk Factors Are Associated With Future Cancer.","volume":"3","author":"Lau","year":"2021","journal-title":"JACC CardioOncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2013viewpoint of the IARC working group.","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.4452","article-title":"A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway.","volume":"24","author":"Lehmann","year":"2018","journal-title":"Nat. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1479-5876-12-196","article-title":"Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma.","volume":"12","author":"Li","year":"2014","journal-title":"J. Transl. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator.","volume":"447","author":"Li","year":"2007","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"crossref","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.","volume":"279","author":"Li","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1096\/fasebj.12.10.971","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha.","volume":"12","author":"Li","year":"1998","journal-title":"FASEB J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"42043","DOI":"10.18632\/oncotarget.14927","article-title":"Tumor suppressor miR-1 inhibits tumor growth and metastasis by simultaneously targeting multiple genes.","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.18632\/aging.102301","article-title":"Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study.","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1101\/gad.1738708","article-title":"microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.","volume":"22","author":"Liu","year":"2008","journal-title":"Genes Dev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry.","volume":"41","author":"Lopez-Sendon","year":"2020","journal-title":"Eur. Heart J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1074\/jbc.M113.470047","article-title":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells.","volume":"288","author":"Ma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","article-title":"Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.","volume":"16","author":"Majewski","year":"2004","journal-title":"Mol. Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"8260742","DOI":"10.1155\/2018\/8260742","article-title":"Myokines as possible therapeutic targets in cancer cachexia.","volume":"2018","author":"Manole","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00726-010-0699-8","article-title":"Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.","volume":"40","author":"Marsh","year":"2011","journal-title":"Amino Acids"},{"key":"B72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/genes9010048","article-title":"PGC1alpha: friend or foe in cancer?","volume":"9","author":"Mastropasqua","year":"2018","journal-title":"Genes (Basel)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ijc.2910490115","article-title":"Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.","volume":"49","author":"Matthys","year":"","journal-title":"Int. J. Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0277-5379(91)90483-t","article-title":"Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia.","volume":"27","author":"Matthys","year":"","journal-title":"Eur. J. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.","volume":"20","author":"Mayers","year":"2014","journal-title":"Nat. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003495-200868040-00009","article-title":"Bevacizumab: a review of its use in metastatic colorectal cancer.","volume":"68","author":"McCormack","year":"2008","journal-title":"Drugs"},{"key":"B77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2049-3002-1-22","article-title":"PGC-1alpha supports glutamine metabolism in breast cancer.","volume":"1","author":"McGuirk","year":"2013","journal-title":"Cancer Metab."},{"key":"B78","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.115.306566","article-title":"Genetics of coronary artery disease.","volume":"118","author":"McPherson","year":"2016","journal-title":"Circ. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer.","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/circulationaha.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors.","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4331\/wjbc.v6.i3.162","article-title":"Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.","volume":"6","author":"Mitchelson","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart.","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/01.hyp.0000144292.69599.0c","article-title":"Mechanisms for increased glycolysis in the hypertrophied rat heart.","volume":"44","author":"Nascimben","year":"2004","journal-title":"Hypertension"},{"key":"B84","first-page":"2319","article-title":"The Akt pathway in oncology therapy and beyond (Review).","volume":"53","author":"Nitulescu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy.","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice.","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.aao5801","article-title":"Obesity and the tumor microenvironment.","volume":"358","author":"Olson","year":"2017","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1073\/pnas.122249299","article-title":"Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy.","volume":"99","author":"Ozcelik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.","volume":"71","author":"Pandey","year":"2018","journal-title":"Hypertension"},{"key":"B90","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","article-title":"Pathogenic gut flora in patients with chronic heart failure.","volume":"4","author":"Pasini","year":"2016","journal-title":"JACC Heart Fail."},{"key":"B91","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"B92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism.","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"B93","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"key":"B94","doi-asserted-by":"crossref","first-page":"N1","DOI":"10.1177\/2047487316653709","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3727\/096504014X14024160459122","article-title":"miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.","volume":"21","author":"Qin","year":"2013","journal-title":"Oncol. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis.","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00392-020-01636-7","article-title":"Onco-cardiology: consensus paper of the german cardiac society, the german society for pediatric cardiology and congenital heart defects and the german society for hematology and medical oncology.","volume":"109","author":"Rassaf","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1128\/MCB.23.20.7315-7328.2003","article-title":"Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.","volume":"23","author":"Rathmell","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10654-017-0231-5","article-title":"Myocardial infarction and future risk of cancer in the general population\u2014the Troms\u00f8 Study.","volume":"32","author":"Rinde","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy.","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells.","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"B102","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molmet.2015.11.004","article-title":"Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.","volume":"5","author":"Schafer","year":"2016","journal-title":"Mol. Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology.","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur. Heart J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1634\/theoncologist.2014-0500","article-title":"Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors.","volume":"20","author":"Serrano","year":"2015","journal-title":"Oncologist"},{"key":"B106","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s1535-6108(02)00039-9","article-title":"Smart drugs: tyrosine kinase inhibitors in cancer therapy.","volume":"1","author":"Shawver","year":"2002","journal-title":"Cancer Cell"},{"key":"B107","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1210\/me.2009-0302","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.","volume":"24","author":"Shiota","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/nejm200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","article-title":"Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.","volume":"13","author":"Staal-van den Brekel","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1152\/japplphysiol.90884.2008","article-title":"Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.","volume":"105","author":"Steffen","year":"2008","journal-title":"J. Appl. Physiol. (1985)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/hypertensionaha.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project.","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"key":"B113","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.biocel.2005.03.013","article-title":"Muscle wasting in cardiac cachexia.","volume":"37","author":"Strassburg","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1172\/jci115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia.","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B115","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.150.6.2341","article-title":"Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.","volume":"150","author":"Strassmann","year":"1993","journal-title":"J. Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients.","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur. Heart J."},{"key":"B117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure.","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e93098","DOI":"10.1172\/jci.insight.93098","article-title":"Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression.","volume":"2","author":"Thackeray","year":"2017","journal-title":"JCI Insight"},{"key":"B119","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00392-018-1202-x","article-title":"Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.","volume":"107","author":"Tilemann","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"B120","doi-asserted-by":"crossref","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.","volume":"8","author":"Tran","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/bbrc.1995.1168","article-title":"Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse.","volume":"207","author":"Tsujinaka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/circulationaha.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death.","volume":"143","author":"Umapathi","year":"2021","journal-title":"Circulation"},{"key":"B123","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/circulationaha.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"B124","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014.","volume":"5","author":"von Haehling","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B125","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e53951","DOI":"10.1371\/journal.pone.0053951","article-title":"Reduced cardiac fructose 2,6 bisphosphate increases hypertrophy and decreases glycolysis following aortic constriction.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"B127","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1128\/MCB.01109-14","article-title":"Enhanced cardiac Akt\/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes.","volume":"35","author":"Wende","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e005234","DOI":"10.1161\/CIRCHEARTFAILURE.118.005234","article-title":"Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle-specific ubiquitin ligase MuRF1.","volume":"12","author":"Willis","year":"2019","journal-title":"Circ Heart Fail."},{"key":"B129","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.humpath.2014.01.017","article-title":"Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia\/lymphoma.","volume":"45","author":"Xia","year":"2014","journal-title":"Hum. Pathol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexmp.2013.05.003","article-title":"Deregulated expression of miR-145 in manifold human cancer cells.","volume":"95","author":"Xing","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1200\/jco.2001.19.1.37","article-title":"Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.","volume":"19","author":"Zambetti","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity.","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCRESAHA.115.303970","article-title":"MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells.","volume":"116","author":"Zhao","year":"2015","journal-title":"Circ. Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.729713\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T15:42:11Z","timestamp":1673883731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.729713\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":135,"alternative-id":["10.3389\/fphys.2021.729713"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.729713","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"article-number":"729713"}}